Skip to Content

Pneumococcal Vaccination of Patients with Autoimmune Inflammatory Rheumatic Diseases

Pneumococcal vaccination might prevent the risk of serious pneumococcal infection in patients with autoimmune inflammatory rheumatic diseases (AIIRD). However, a study of the antibody response in patients with AIIRD showed that only 36% achieved a protective antibody level after pneumococcal vaccination.

Få tilgang

Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.

Back to top